9999999997-15-014306.txt : 20151027 9999999997-15-014306.hdr.sgml : 20151027 20151027140716 ACCESSION NUMBER: 9999999997-15-014306 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151027 DATE AS OF CHANGE: 20151027 20151027 20151027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOPHIRIS BIO INC. CENTRAL INDEX KEY: 0001563855 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-186724 FILM NUMBER: 151177508 BUSINESS ADDRESS: STREET 1: 1258 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-777-1760 MAIL ADDRESS: STREET 1: 1258 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end